Latest News - Syneron

Monday, April 03, 2017 | Acquisitions and Mergers, PracticalDermatology.com, Syneron

Apax Partners To Acquire Syneron for Close to $400 million

An affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of Syneron Candela for $11.00 per share in cash in a transaction valued at approximately $397 m…

Read the full story

Tuesday, February 14, 2017 | Acquisitions and Mergers, PracticalDermatology.com, Allergan , Cool Sculpting, Cynosure, PicoWay, Profound, Syneron, Tattoo , Zeltiq

Rumor Has It Syneron Is Next In Week of Surprising Aquisitions

Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners…

Read the full story

Tuesday, November 08, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Syneron

FDA Clears Syneron Candela's Profound SubQ to Improve Cellulite

Syneron Candela  received FDA 510(k) clearance for Profound when using the SubQ handpiece and cartridge to improve the appearance of cellulite in patients with Fitzpatrick skin types I-III, as su…

Read the full story

Wednesday, August 10, 2016 | PracticalDermatology.com, Practice Development, Cynosure, Merz, Syneron, Zeltiq

Men, New Technologies Drive Growth in Body Contouring Market

The body contouring market is set to rise from $671.8 million in 2015 to more than $1.1 billion by 2022, representing a compound annual growth rate of 7.9%, according to research and consulting firm G…

Read the full story

Monday, July 25, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Syneron

Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-Short 785nm Wavelength

And then there were three. The U.S. Food and Drug Administration (FDA) has cleared Syneron Medical Ltd.’s PicoWay® picosecond laser for a new ultra-short 785nm wavelength. The add…

Read the full story

Monday, July 18, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Syneron

FDA Clears Syneron Candela's UltraShape Power for Fat Destruction

The FDA cleared Syneron Medical Ltd.'s non-invasive fat destruction device, UltraShape Power. for non-invasive reduction of abdominal circumference via fat cell destruction. UltraShape Power us…

Read the full story

Tuesday, March 29, 2016 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications, Cynosure, Lutronics, Merz, Syneron

North America's Scar Treatment Poised for Growth Spurt by 2022

Scar treatment will be a hot growth area in coming years, according to a new report by Persistence Market Research. The report cites a rising incidence of burn and trauma cases and an increasi…

Read the full story

Sunday, March 06, 2016 | Acquisitions and Mergers, PracticalDermatology.com, Allergan , Syneron

APP® Membership Now Has More Rewards: Three Syneron Candela Platforms

Syneron Medical Ltd. and Allergan plc are joining forces to offer three of Syneron Candela's body sculpting and skincare platforms to members of Allergan Partner Privileges® (APP®). …

Read the full story

Friday, March 04, 2016 | PracticalDermatology.com, Product Launches and Updates, Syneron

Syneron Candela Introducing New Technologies at the 2016 AAD Annual Meeting

Syneron Medical Ltd., is launching three new products during the 2016 American Academy of Dermatology (AAD) meeting in Washington, DC. The launches include the new CO2RE Intima system for gynecologica…

Read the full story

Wednesday, November 11, 2015 | Personnel/Company News, PracticalDermatology.com, Syneron

Syneron Appoints Jeff Nardoci as President of North America Body Shaping Group

Syneron Medical Ltd., a leading global aesthetic device company, appointed Jeff Nardoci as President of its North America Body Shaping Group. In this position, Mr. Nardoci will be responsible for the …

Read the full story

Thursday, November 05, 2015 | FDA Approval/Clearance, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Syneron

Syneron Candela Announces New FDA Clearance for the CO2RE System

The FDA has granted numerous additional indications for use of Syneron Medical Ltd.’s CO2RE CO2 device. This clearance, including more than 90 specific indications in total, significantly expand…

Read the full story

Thursday, November 05, 2015 | Research and Publications, Syneron

New Tattoo Survey Shows Tattoo Acceptance Up; Tattoo Regret Still an Issue

With nearly 40 percent of Americans ages 18-29 sporting ink, body art has not only become mainstream, but can actually up someone's stock. In a recent Syneron Candela survey, attitudes toward peop…

Read the full story

Thursday, October 08, 2015 | PracticalDermatology.com, Product Launches and Updates, Syneron

Syneron Introduces PicoWay Resolve

Syneron Medical Ltd. introduced the PicoWay Resolve™, a dual wavelength fractional modality for the PicoWay picosecond laser, at the 24th European Academy of Dermatology and Venereology (EADV) C…

Read the full story

Monday, May 18, 2015 | Personnel/Company News, PracticalDermatology.com, Practice Development, Product Launches and Updates, Syneron

TV Star, Mother of Four Larsa Pippen Shares Her UltraShape Story

UltraShape’s newest devotee, Larsa Pippen, Real Housewives of Miami Alumni, wife of six-time world champion NBA star Scottie Pippen, and fitness enthusiast, recently talked about her UltraShape …

Read the full story

Monday, April 20, 2015 | FDA Approval/Clearance, PracticalDermatology.com, Syneron

FDA Clears Syneron Candela's PicoWay Picosecond Laser for Treatment of Pigmented Lesions

The FDA cleared Syneron Medical Ltd.’s PicoWay® picosecond laser for the treatment of pigmented lesions. The PicoWay picosecond laser previously received FDA clearance for the removal of tat…

Read the full story
Load More